A groundbreaking prognostic test developed through collaboration between The University of Western Australia and Perth-based Proteomics International has been highlighted as the most prominent translational outcome in diabetes research by the National Health and Medical Research Council (NHMRC).
In a recent national report evaluating outcomes of NHMRC-funded programs in diabetes from 2000 to 2023, PromarkerD was recognised for its significant advancement in the clinical prediction of diabetic kidney disease.
